Healios K.K. (OTCMKTS:HLOSF – Get Free Report) rose 5.6% during mid-day trading on Thursday . The stock traded as high as 0.99 and last traded at 0.99. Approximately 200 shares traded hands during mid-day trading, a decline of 84% from the average daily volume of 1,260 shares. The stock had previously closed at 0.94.
Healios K.K. Price Performance
The firm’s 50-day moving average price is 0.94 and its 200-day moving average price is 1.26.
About Healios K.K.
Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease.
Further Reading
- Five stocks we like better than Healios K.K.
- Upcoming IPO Stock Lockup Period, Explained
- MarketBeat Week in Review – 4/22 – 4/26
- 3 Tickers Leading a Meme Stock Revival
- 3 Stocks Leading the U.S. Agriculture Comeback
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Healios K.K. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healios K.K. and related companies with MarketBeat.com's FREE daily email newsletter.
